SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001140361-21-019900
Filing Date
2021-06-04
Accepted
2021-06-04 16:14:26
Documents
11

Document Format Files

Seq Description Document Type Size
1 F-1 nt10022430x2_f1.htm F-1 2846311
2 EXHIBIT 5.1 nt10022430x2_ex5-1.htm EX-5.1 61576
3 EXHIBIT 21.1 nt10022430x2_ex21-1.htm EX-21.1 2188
4 EXHIBIT 23.1 nt10022430x2_ex23-1.htm EX-23.1 1841
5 logo_ghhealth.jpg GRAPHIC 41620
6 nt10022430x1_ex5-1image01.jpg GRAPHIC 7294
7 nt10022430x2_barchart1a.jpg GRAPHIC 239516
8 nt10022430x2_barchart1x2.jpg GRAPHIC 196639
9 nt10022430x2_diagram2.jpg GRAPHIC 211843
10 nt10022430x2_diagram3.jpg GRAPHIC 163961
11 nt10022430x2_molecules.jpg GRAPHIC 49396
  Complete submission text file 0001140361-21-019900.txt   4165586
Mailing Address 28 BAGGOT STREET LOWER DUBLIN L2 2D02 NX43
Business Address 28 BAGGOT STREET LOWER DUBLIN L2 2D02 NX43 41 76 3603200
GH Research PLC (Filer) CIK: 0001855129 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-256796 | Film No.: 21996613
SIC: 2834 Pharmaceutical Preparations